GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST
TPE:3164 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 44.89 | 57.2 | 57.25 | 32.99 | 56.98 | 113.13 |
Depreciation & Amortization | 66.48 | 66.56 | 71.2 | 64.6 | 50.32 | 21.04 |
Other Amortization | 0.39 | 0.39 | 0.39 | 0.18 | 0.1 | 0.09 |
Loss (Gain) From Sale of Assets | 0 | 0 | 0.02 | -0.28 | 0.06 | -3.74 |
Loss (Gain) From Sale of Investments | -4.38 | -4.02 | 1.23 | -19.05 | 8.16 | -9.35 |
Provision & Write-off of Bad Debts | 7.33 | 0.73 | -0.52 | 0.74 | -1.79 | 3.3 |
Other Operating Activities | -26.06 | -20.78 | -28.25 | -24.72 | -23.56 | 9.56 |
Change in Accounts Receivable | -15.33 | -15.33 | 7.18 | 11.32 | 5.67 | -14.96 |
Change in Inventory | 5.36 | 7.07 | 10.1 | -31.67 | -18.21 | -2.28 |
Change in Accounts Payable | 1.82 | 1.82 | -1.55 | -6.51 | 2.98 | 4 |
Change in Unearned Revenue | -17.57 | -17.97 | 6.07 | 8.22 | 0.43 | 1.03 |
Change in Other Net Operating Assets | -5.37 | -2.08 | 0.82 | -1.21 | 55.85 | -10.17 |
Operating Cash Flow | 57.58 | 73.6 | 123.95 | 34.6 | 136.98 | 111.66 |
Operating Cash Flow Growth | -47.73% | -40.62% | 258.24% | -74.74% | 22.68% | -5.59% |
Capital Expenditures | -3.49 | -3.41 | -44.05 | -33.31 | -71.19 | -116.94 |
Sale of Property, Plant & Equipment | - | - | - | 0.28 | 0.24 | - |
Sale (Purchase) of Intangibles | -0.25 | -0.25 | -0.22 | -2.23 | - | -0.18 |
Sale (Purchase) of Real Estate | - | - | - | - | - | 21.98 |
Investment in Securities | 33.81 | 3.68 | 27.58 | 23.18 | -13.62 | -57.96 |
Other Investing Activities | 7.8 | 7.67 | -65.73 | -63.3 | 1.83 | 0.02 |
Investing Cash Flow | 37.88 | 7.7 | -82.42 | -75.37 | -82.73 | -153.07 |
Short-Term Debt Issued | - | 45.84 | 42.17 | - | - | - |
Long-Term Debt Issued | - | - | 43.65 | 22.7 | - | - |
Total Debt Issued | 45.73 | 45.84 | 85.82 | 22.7 | - | - |
Short-Term Debt Repaid | - | -43.01 | -21.8 | - | - | - |
Long-Term Debt Repaid | - | -11.93 | -8.16 | -1.87 | -1.43 | -1.6 |
Total Debt Repaid | -46.84 | -54.94 | -29.96 | -1.87 | -1.43 | -1.6 |
Net Debt Issued (Repaid) | -1.1 | -9.09 | 55.86 | 20.83 | -1.43 | -1.6 |
Issuance of Common Stock | - | - | - | 2.81 | - | 0.67 |
Repurchase of Common Stock | -10.33 | -10.33 | - | - | - | - |
Common Dividends Paid | -69.21 | -69.21 | -43.26 | -60.46 | -95.01 | -60.44 |
Other Financing Activities | - | - | -0.05 | - | 5.35 | - |
Financing Cash Flow | -80.65 | -88.64 | 12.55 | -36.82 | -91.09 | -61.37 |
Foreign Exchange Rate Adjustments | 1.18 | 0.56 | 0.84 | -0.5 | 0.58 | -2.11 |
Net Cash Flow | 15.99 | -6.78 | 54.92 | -78.09 | -36.27 | -104.89 |
Free Cash Flow | 54.09 | 70.19 | 79.89 | 1.29 | 65.79 | -5.28 |
Free Cash Flow Growth | -44.35% | -12.14% | 6088.38% | -98.04% | - | - |
Free Cash Flow Margin | 13.84% | 17.49% | 20.73% | 0.41% | 17.85% | -1.23% |
Free Cash Flow Per Share | 0.63 | 0.81 | 0.92 | 0.01 | 0.76 | -0.06 |
Cash Interest Paid | 3.92 | 3.92 | 3.72 | 0.97 | 0.76 | 0.77 |
Cash Income Tax Paid | 12.9 | 12.9 | 29.92 | 28.58 | 34.34 | 16.73 |
Levered Free Cash Flow | 76.22 | 82.27 | -32.26 | -1.57 | 78.65 | -2.42 |
Unlevered Free Cash Flow | 78.57 | 84.72 | -29.94 | -0.96 | 79.13 | -1.94 |
Change in Working Capital | -31.09 | -26.49 | 22.62 | -19.85 | 46.71 | -22.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.